Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.

Identifieur interne : 000459 ( PubMed/Checkpoint ); précédent : 000458; suivant : 000460

Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.

Auteurs : M. Austin Taylor [États-Unis] ; M. Bennett ; V. Kumar ; J D Schatzle

Source :

RBID : pubmed:11046034

Descripteurs français

English descriptors

Abstract

NK cells are the primary effectors mediating acute rejection of incompatible bone marrow cell grafts. To reduce rejection, we evaluated the ability of chloroquine (CHQ) to prevent perforin-dependent NK cell activity. Perforin is a key cytotoxic component released from the lytic granules of activated NK cells. Generation of functional perforin requires an acidic protease activity that occurs in the secretory, lytic lysosomes. Our hypothesis was that CHQ, a lysosomotropic reagent, would raise the pH of the acidic compartment in which perforin is processed and thereby block perforin maturation and cytotoxicity. We have measured NK cytotoxicity in vivo by clearance of YAC-1 tumor cells from the lungs and by rejection of incompatible bone marrow transplants and in vitro by cytolysis of YAC-1 and Jurkat cells. The engraftment of bone marrow cells was monitored by recolonization of the spleen with hemopoietic cells from transplants of MHC class I-deficient bone marrow cells into lethally irradiated recipient mice. Transplant rejection was compared in two inbred strains of mice: 129, which apparently use perforin-dependent cytotoxicity, and C57BL/6, in which rejection can be perforin-independent. CHQ treatment reduced NK cell activity in 129 mice in which perforin is important for mediating rejection. CHQ affected the fraction of NK cell cytolysis that was Fas independent. In addition, we found that CHQ prevents perforin processing by LAK cells in vitro. These data indicate that CHQ may impair rejection of incompatible bone marrow transplants and other functions mediated by NK and cytotoxic T cells.

DOI: 10.4049/jimmunol.165.9.5048
PubMed: 11046034


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:11046034

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.</title>
<author>
<name sortKey="Austin Taylor, M" sort="Austin Taylor, M" uniqKey="Austin Taylor M" first="M" last="Austin Taylor">M. Austin Taylor</name>
<affiliation wicri:level="2">
<nlm:affiliation>Graduate Program in Immunology, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. austin01@utsw.swmed.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Graduate Program in Immunology, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bennett, M" sort="Bennett, M" uniqKey="Bennett M" first="M" last="Bennett">M. Bennett</name>
</author>
<author>
<name sortKey="Kumar, V" sort="Kumar, V" uniqKey="Kumar V" first="V" last="Kumar">V. Kumar</name>
</author>
<author>
<name sortKey="Schatzle, J D" sort="Schatzle, J D" uniqKey="Schatzle J" first="J D" last="Schatzle">J D Schatzle</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:11046034</idno>
<idno type="pmid">11046034</idno>
<idno type="doi">10.4049/jimmunol.165.9.5048</idno>
<idno type="wicri:Area/PubMed/Corpus">000478</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000478</idno>
<idno type="wicri:Area/PubMed/Curation">000478</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000478</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000459</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000459</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.</title>
<author>
<name sortKey="Austin Taylor, M" sort="Austin Taylor, M" uniqKey="Austin Taylor M" first="M" last="Austin Taylor">M. Austin Taylor</name>
<affiliation wicri:level="2">
<nlm:affiliation>Graduate Program in Immunology, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. austin01@utsw.swmed.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Graduate Program in Immunology, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bennett, M" sort="Bennett, M" uniqKey="Bennett M" first="M" last="Bennett">M. Bennett</name>
</author>
<author>
<name sortKey="Kumar, V" sort="Kumar, V" uniqKey="Kumar V" first="V" last="Kumar">V. Kumar</name>
</author>
<author>
<name sortKey="Schatzle, J D" sort="Schatzle, J D" uniqKey="Schatzle J" first="J D" last="Schatzle">J D Schatzle</name>
</author>
</analytic>
<series>
<title level="j">Journal of immunology (Baltimore, Md. : 1950)</title>
<idno type="ISSN">0022-1767</idno>
<imprint>
<date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Bone Marrow Cells (drug effects)</term>
<term>Bone Marrow Cells (immunology)</term>
<term>Bone Marrow Transplantation (immunology)</term>
<term>Cell Movement (drug effects)</term>
<term>Cell Movement (immunology)</term>
<term>Cells, Cultured</term>
<term>Chloroquine (pharmacology)</term>
<term>Cytotoxicity, Immunologic (drug effects)</term>
<term>Cytotoxicity, Immunologic (genetics)</term>
<term>Fas Ligand Protein</term>
<term>Graft Rejection (genetics)</term>
<term>Graft Rejection (immunology)</term>
<term>Graft Rejection (prevention & control)</term>
<term>Histocompatibility Antigens Class I (genetics)</term>
<term>Humans</term>
<term>Immunosuppressive Agents (pharmacology)</term>
<term>Injections, Intravenous</term>
<term>Jurkat Cells</term>
<term>Killer Cells, Natural (drug effects)</term>
<term>Killer Cells, Natural (immunology)</term>
<term>Killer Cells, Natural (transplantation)</term>
<term>Ligands</term>
<term>Lung Neoplasms (immunology)</term>
<term>Lung Neoplasms (pathology)</term>
<term>Lung Neoplasms (prevention & control)</term>
<term>Membrane Glycoproteins (antagonists & inhibitors)</term>
<term>Membrane Glycoproteins (deficiency)</term>
<term>Membrane Glycoproteins (genetics)</term>
<term>Membrane Glycoproteins (metabolism)</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Mice, Inbred Strains</term>
<term>Mice, Knockout</term>
<term>Perforin</term>
<term>Pore Forming Cytotoxic Proteins</term>
<term>Protein Processing, Post-Translational (drug effects)</term>
<term>Protein Processing, Post-Translational (immunology)</term>
<term>Tumor Cells, Cultured (drug effects)</term>
<term>Tumor Cells, Cultured (immunology)</term>
<term>Tumor Cells, Cultured (pathology)</term>
<term>fas Receptor (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Antigènes d'histocompatibilité de classe I (génétique)</term>
<term>Cellules Jurkat</term>
<term>Cellules cancéreuses en culture ()</term>
<term>Cellules cancéreuses en culture (anatomopathologie)</term>
<term>Cellules cancéreuses en culture (immunologie)</term>
<term>Cellules cultivées</term>
<term>Cellules de la moelle osseuse ()</term>
<term>Cellules de la moelle osseuse (immunologie)</term>
<term>Cellules tueuses naturelles ()</term>
<term>Cellules tueuses naturelles (immunologie)</term>
<term>Cellules tueuses naturelles (transplantation)</term>
<term>Chloroquine (pharmacologie)</term>
<term>Cytotoxicité immunologique ()</term>
<term>Cytotoxicité immunologique (génétique)</term>
<term>Glycoprotéines membranaires (antagonistes et inhibiteurs)</term>
<term>Glycoprotéines membranaires (déficit)</term>
<term>Glycoprotéines membranaires (génétique)</term>
<term>Glycoprotéines membranaires (métabolisme)</term>
<term>Humains</term>
<term>Immunosuppresseurs (pharmacologie)</term>
<term>Injections veineuses</term>
<term>Ligand de Fas</term>
<term>Ligands</term>
<term>Lignées consanguines de souris</term>
<term>Maturation post-traductionnelle des protéines ()</term>
<term>Maturation post-traductionnelle des protéines (immunologie)</term>
<term>Mouvement cellulaire ()</term>
<term>Mouvement cellulaire (immunologie)</term>
<term>Perforine</term>
<term>Perforines</term>
<term>Rejet du greffon ()</term>
<term>Rejet du greffon (génétique)</term>
<term>Rejet du greffon (immunologie)</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Souris knockout</term>
<term>Transplantation de moelle osseuse (immunologie)</term>
<term>Tumeurs du poumon ()</term>
<term>Tumeurs du poumon (anatomopathologie)</term>
<term>Tumeurs du poumon (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Membrane Glycoproteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="deficiency" xml:lang="en">
<term>Membrane Glycoproteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Histocompatibility Antigens Class I</term>
<term>Membrane Glycoproteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>fas Receptor</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Chloroquine</term>
<term>Immunosuppressive Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Cellules cancéreuses en culture</term>
<term>Tumeurs du poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Glycoprotéines membranaires</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Bone Marrow Cells</term>
<term>Cell Movement</term>
<term>Cytotoxicity, Immunologic</term>
<term>Killer Cells, Natural</term>
<term>Protein Processing, Post-Translational</term>
<term>Tumor Cells, Cultured</term>
</keywords>
<keywords scheme="MESH" qualifier="déficit" xml:lang="fr">
<term>Glycoprotéines membranaires</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Cytotoxicity, Immunologic</term>
<term>Graft Rejection</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Antigènes d'histocompatibilité de classe I</term>
<term>Cytotoxicité immunologique</term>
<term>Glycoprotéines membranaires</term>
<term>Rejet du greffon</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Cellules cancéreuses en culture</term>
<term>Cellules de la moelle osseuse</term>
<term>Cellules tueuses naturelles</term>
<term>Maturation post-traductionnelle des protéines</term>
<term>Mouvement cellulaire</term>
<term>Rejet du greffon</term>
<term>Transplantation de moelle osseuse</term>
<term>Tumeurs du poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Bone Marrow Cells</term>
<term>Bone Marrow Transplantation</term>
<term>Cell Movement</term>
<term>Graft Rejection</term>
<term>Killer Cells, Natural</term>
<term>Lung Neoplasms</term>
<term>Protein Processing, Post-Translational</term>
<term>Tumor Cells, Cultured</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Glycoprotéines membranaires</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Lung Neoplasms</term>
<term>Tumor Cells, Cultured</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Chloroquine</term>
<term>Immunosuppresseurs</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Graft Rejection</term>
<term>Lung Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="transplantation" xml:lang="en">
<term>Killer Cells, Natural</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cells, Cultured</term>
<term>Fas Ligand Protein</term>
<term>Humans</term>
<term>Injections, Intravenous</term>
<term>Jurkat Cells</term>
<term>Ligands</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Mice, Inbred Strains</term>
<term>Mice, Knockout</term>
<term>Perforin</term>
<term>Pore Forming Cytotoxic Proteins</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules Jurkat</term>
<term>Cellules cancéreuses en culture</term>
<term>Cellules cultivées</term>
<term>Cellules de la moelle osseuse</term>
<term>Cellules tueuses naturelles</term>
<term>Cytotoxicité immunologique</term>
<term>Humains</term>
<term>Injections veineuses</term>
<term>Ligand de Fas</term>
<term>Ligands</term>
<term>Lignées consanguines de souris</term>
<term>Maturation post-traductionnelle des protéines</term>
<term>Mouvement cellulaire</term>
<term>Perforine</term>
<term>Perforines</term>
<term>Rejet du greffon</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Souris knockout</term>
<term>Tumeurs du poumon</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">NK cells are the primary effectors mediating acute rejection of incompatible bone marrow cell grafts. To reduce rejection, we evaluated the ability of chloroquine (CHQ) to prevent perforin-dependent NK cell activity. Perforin is a key cytotoxic component released from the lytic granules of activated NK cells. Generation of functional perforin requires an acidic protease activity that occurs in the secretory, lytic lysosomes. Our hypothesis was that CHQ, a lysosomotropic reagent, would raise the pH of the acidic compartment in which perforin is processed and thereby block perforin maturation and cytotoxicity. We have measured NK cytotoxicity in vivo by clearance of YAC-1 tumor cells from the lungs and by rejection of incompatible bone marrow transplants and in vitro by cytolysis of YAC-1 and Jurkat cells. The engraftment of bone marrow cells was monitored by recolonization of the spleen with hemopoietic cells from transplants of MHC class I-deficient bone marrow cells into lethally irradiated recipient mice. Transplant rejection was compared in two inbred strains of mice: 129, which apparently use perforin-dependent cytotoxicity, and C57BL/6, in which rejection can be perforin-independent. CHQ treatment reduced NK cell activity in 129 mice in which perforin is important for mediating rejection. CHQ affected the fraction of NK cell cytolysis that was Fas independent. In addition, we found that CHQ prevents perforin processing by LAK cells in vitro. These data indicate that CHQ may impair rejection of incompatible bone marrow transplants and other functions mediated by NK and cytotoxic T cells.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">11046034</PMID>
<DateCompleted>
<Year>2000</Year>
<Month>11</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>05</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0022-1767</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>165</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2000</Year>
<Month>Nov</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
<ISOAbbreviation>J. Immunol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.</ArticleTitle>
<Pagination>
<MedlinePgn>5048-53</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>NK cells are the primary effectors mediating acute rejection of incompatible bone marrow cell grafts. To reduce rejection, we evaluated the ability of chloroquine (CHQ) to prevent perforin-dependent NK cell activity. Perforin is a key cytotoxic component released from the lytic granules of activated NK cells. Generation of functional perforin requires an acidic protease activity that occurs in the secretory, lytic lysosomes. Our hypothesis was that CHQ, a lysosomotropic reagent, would raise the pH of the acidic compartment in which perforin is processed and thereby block perforin maturation and cytotoxicity. We have measured NK cytotoxicity in vivo by clearance of YAC-1 tumor cells from the lungs and by rejection of incompatible bone marrow transplants and in vitro by cytolysis of YAC-1 and Jurkat cells. The engraftment of bone marrow cells was monitored by recolonization of the spleen with hemopoietic cells from transplants of MHC class I-deficient bone marrow cells into lethally irradiated recipient mice. Transplant rejection was compared in two inbred strains of mice: 129, which apparently use perforin-dependent cytotoxicity, and C57BL/6, in which rejection can be perforin-independent. CHQ treatment reduced NK cell activity in 129 mice in which perforin is important for mediating rejection. CHQ affected the fraction of NK cell cytolysis that was Fas independent. In addition, we found that CHQ prevents perforin processing by LAK cells in vitro. These data indicate that CHQ may impair rejection of incompatible bone marrow transplants and other functions mediated by NK and cytotoxic T cells.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Austin Taylor</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Graduate Program in Immunology, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. austin01@utsw.swmed.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bennett</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schatzle</LastName>
<ForeName>J D</ForeName>
<Initials>JD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>AI38938</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA36922</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA70134</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Immunol</MedlineTA>
<NlmUniqueID>2985117R</NlmUniqueID>
<ISSNLinking>0022-1767</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C505661">FASLG protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053222">Fas Ligand Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C505658">Fasl protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015395">Histocompatibility Antigens Class I</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008024">Ligands</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D052899">Pore Forming Cytotoxic Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019014">fas Receptor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>126465-35-8</RegistryNumber>
<NameOfSubstance UI="D054353">Perforin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001854" MajorTopicYN="N">Bone Marrow Cells</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016026" MajorTopicYN="N">Bone Marrow Transplantation</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003602" MajorTopicYN="N">Cytotoxicity, Immunologic</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053222" MajorTopicYN="N">Fas Ligand Protein</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006084" MajorTopicYN="N">Graft Rejection</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015395" MajorTopicYN="N">Histocompatibility Antigens Class I</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007275" MajorTopicYN="N">Injections, Intravenous</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019169" MajorTopicYN="N">Jurkat Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000637" MajorTopicYN="N">transplantation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054353" MajorTopicYN="N">Perforin</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D052899" MajorTopicYN="N">Pore Forming Cytotoxic Proteins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019014" MajorTopicYN="N">fas Receptor</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2000</Year>
<Month>10</Month>
<Day>25</Day>
<Hour>11</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2001</Year>
<Month>2</Month>
<Day>28</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2000</Year>
<Month>10</Month>
<Day>25</Day>
<Hour>11</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">11046034</ArticleId>
<ArticleId IdType="doi">10.4049/jimmunol.165.9.5048</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Texas</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Bennett, M" sort="Bennett, M" uniqKey="Bennett M" first="M" last="Bennett">M. Bennett</name>
<name sortKey="Kumar, V" sort="Kumar, V" uniqKey="Kumar V" first="V" last="Kumar">V. Kumar</name>
<name sortKey="Schatzle, J D" sort="Schatzle, J D" uniqKey="Schatzle J" first="J D" last="Schatzle">J D Schatzle</name>
</noCountry>
<country name="États-Unis">
<region name="Texas">
<name sortKey="Austin Taylor, M" sort="Austin Taylor, M" uniqKey="Austin Taylor M" first="M" last="Austin Taylor">M. Austin Taylor</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000459 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000459 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:11046034
   |texte=   Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:11046034" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021